title: Ebola: public-private partnerships.
authors.affiliation: Artemis One Health Research Foundation, 3584 CL Utrecht, Netherlands. Department of Viroscience, Erasmus MC, 3000 CA Rotterdam, Netherlands.
authors.forename: L A
authors.initials: LA
authors.lastname: Reperant
authors.affiliation: Athena Institute, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, Netherlands.
authors.forename: L H M
authors.initials: LH
authors.lastname: van de Burgwal
authors.affiliation: Artemis One Health Research Foundation, 3584 CL Utrecht, Netherlands. Athena Institute, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, Netherlands.
authors.forename: E
authors.initials: E
authors.lastname: Claassen
authors.affiliation: Artemis One Health Research Foundation, 3584 CL Utrecht, Netherlands. Department of Viroscience, Erasmus MC, 3000 CA Rotterdam, Netherlands. a.osterhaus@erasmusmc.nl.
authors.forename: A D M E
authors.initials: AD
authors.lastname: Osterhaus
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D003140:Communicable Disease Control / Q000191:economics / Q000379:methods*; D055808:Drug Discovery; D046129:Ebola Vaccines / Q000008:administration & dosage; D029043:Ebolavirus; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D054579:National Institute of Allergy and Infectious Diseases (U.S.); D017149:Private Sector / Q000191:economics; D017150:Public Sector / Q000191:economics; D055818:Public-Private Sector Partnerships / Q000191:economics*; D014481:United States; D014611:Vaccination
chemical_list: D000998:Antiviral Agents; D046129:Ebola Vaccines